IRIS
SOLLA, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.666
AS - Asia 3.427
SA - Sud America 2.872
EU - Europa 1.011
AF - Africa 175
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 8
Totale 13.173
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.504
BR - Brasile 2.529
SG - Singapore 1.675
CN - Cina 528
VN - Vietnam 371
HK - Hong Kong 309
IT - Italia 196
DE - Germania 187
AR - Argentina 137
UA - Ucraina 123
FI - Finlandia 103
GB - Regno Unito 80
CA - Canada 72
RU - Federazione Russa 71
BD - Bangladesh 61
TR - Turchia 58
EC - Ecuador 56
MX - Messico 56
ZA - Sudafrica 56
IN - India 52
IQ - Iraq 49
ID - Indonesia 47
FR - Francia 39
MA - Marocco 39
UZ - Uzbekistan 36
VE - Venezuela 35
PK - Pakistan 33
CO - Colombia 30
ES - Italia 27
NL - Olanda 24
PY - Paraguay 24
AT - Austria 23
PE - Perù 23
AE - Emirati Arabi Uniti 22
JP - Giappone 22
PL - Polonia 21
TN - Tunisia 20
SE - Svezia 19
AZ - Azerbaigian 18
CZ - Repubblica Ceca 18
KE - Kenya 17
TH - Thailandia 16
JO - Giordania 15
NP - Nepal 15
UY - Uruguay 15
EG - Egitto 14
MY - Malesia 13
PH - Filippine 13
BE - Belgio 12
CL - Cile 12
LT - Lituania 11
CR - Costa Rica 9
EU - Europa 9
OM - Oman 9
AU - Australia 8
BO - Bolivia 8
DZ - Algeria 8
GR - Grecia 7
AL - Albania 6
IL - Israele 6
JM - Giamaica 6
KG - Kirghizistan 6
KR - Corea 6
LB - Libano 6
RS - Serbia 6
HN - Honduras 5
IE - Irlanda 5
KZ - Kazakistan 5
PS - Palestinian Territory 5
RO - Romania 5
SA - Arabia Saudita 5
SN - Senegal 5
AO - Angola 4
BG - Bulgaria 4
BN - Brunei Darussalam 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
GE - Georgia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
GT - Guatemala 3
HU - Ungheria 3
LU - Lussemburgo 3
PA - Panama 3
DK - Danimarca 2
EE - Estonia 2
GY - Guiana 2
IR - Iran 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MN - Mongolia 2
NG - Nigeria 2
QA - Qatar 2
TJ - Tagikistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BF - Burkina Faso 1
Totale 13.155
Salva come PNG Salva come JPEG
Città #
Dallas 3.063
Singapore 847
Chandler 513
Hong Kong 305
Ashburn 227
Princeton 222
Beijing 172
São Paulo 159
Ho Chi Minh City 133
Shanghai 107
Los Angeles 89
Rio de Janeiro 83
Helsinki 80
Hanoi 78
Belo Horizonte 72
New York 67
Munich 55
Santa Clara 55
Brasília 52
Wilmington 46
Jacksonville 37
Johannesburg 36
The Dalles 36
Campinas 35
Porto Alegre 35
Tashkent 33
Columbus 31
Curitiba 27
Cagliari 26
Guarulhos 25
Montreal 25
Jakarta 24
Nuremberg 24
Quito 24
Salvador 24
Brooklyn 23
Buenos Aires 23
Denver 23
Haiphong 23
Toronto 23
Falls Church 22
Rome 22
Orem 21
Tokyo 21
Baghdad 20
Mexico City 20
San Jose 20
Warsaw 20
Atlanta 19
Frankfurt am Main 19
London 19
Lima 18
Campo Grande 17
Düsseldorf 17
Recife 17
Baku 16
Fortaleza 16
Franca 16
Juiz de Fora 16
Poplar 16
San Francisco 16
Amman 15
Bangkok 15
Contagem 15
Da Nang 15
Manaus 15
Ribeirão Preto 15
Turku 15
Amsterdam 14
Asunción 14
Chennai 14
Council Bluffs 14
Guayaquil 14
Santo André 14
Sorocaba 14
Tianjin 14
Betim 13
Dhaka 13
Falkenstein 13
Florianópolis 13
Mauá 13
Nairobi 13
Stockholm 13
São José do Rio Preto 13
Uberlândia 13
Boston 12
Brussels 12
Cape Town 12
Guangzhou 12
Limeira 12
Montevideo 12
Osasco 12
Ankara 11
Casablanca 11
Goiânia 11
Istanbul 11
Joinville 11
Sassari 11
Taubaté 11
Várzea Paulista 11
Totale 7.876
Salva come PNG Salva come JPEG
Nome #
The role of 123I-MIBG cardiac scintigraphy in the patients with movement disorders (MD). 320
Teaching Video NeuroImage: The "Chameleon Eyes Sign" in Myasthenia Gravis 189
Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice 181
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis 159
Herv-k modulates the immune response in als patients 156
The natural history of body-first versus brain-first Parkinson's disease subtypes 149
Adapted physical activity on motor and non-motor symptoms, and quality of life in Parkinson's disease patients 143
Body weight-supported high-intensity locomotor training and adapted physical activity program in patients with Parkinson's disease: a complementary approach? 140
An Ancient Tradition, A New Kind Of Physical Activity: The Sardinian Folk Dance ‘Ballu Sardu’ 135
Diagnostic Value of the "Insular Knife-Cut" Sign in Patients With Suspected Herpes Simplex Virus Encephalitis 133
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. 133
Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis 132
Early discontinuation and titration strategies in foslevodopa/foscarbidopa therapy for Parkinson's disease 131
Navigating the Neuropsychiatric Risks of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease 128
Bipolar affective disorder and Parkinson's disease: A rare, insidious and often unrecognized association 128
A new type of physical activity from an ancient tradition: the Sardinian folk dance "ballu sardu" 126
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa-Carbidopa Intestinal Gel: A Nation-Wide, Multicenter, Longitudinal, "Real-World" Study. The EPIC Study 125
Clinical Significance of Myelin Oligodendrocyte Glycoprotein Autoantibodies in Patients with Typical MS Lesions on MRI 124
Behavioral, neuropsychiatric and cognitive disorders in Parkinson's disease patients with and without motor complications 123
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study 122
An unusual delusion of duplication in a patient affected by Dementia with Lewy bodies 122
18F-FDG Brain PET/CT Metabolic Imaging in Patients with Suspected Autoimmune Encephalitis (AE) in the Early Stage: Can the Procedure Play a Complementary Diagnostic Role? 120
Alternating or metronome pisa syndrome in patients under drugs acting on dopaminergic pathways 119
Aberrant sexual behaviours in Parkinson's disease during dopaminergic treatment [2] 119
Author Response: Teaching Video NeuroImage: Bilateral Hemifacial Spasm in Giant Cell Arteritis 118
C9ORF72 Intermediate Repeat Expansion in a Patient with Psychiatric Disorders and Progressive Cerebellar Ataxia 117
Drosophila mutant model of Parkinson's disease revealed an unexpected olfactory performance: Morphofunctional evidences 116
[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism 115
Functional and morphological correlates in the drosophila LRRK2 loss-of-function model of Parkinson's disease: Drug effects of withania somnifera (Dunal) administration 111
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients 111
Exposure to TNF inhibitors is rare at MOGAD presentation 107
Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study 103
Autoimmune encephalitis misdiagnosis and mimics 98
Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD 96
Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients 96
Association between olfactory dysfunction and motor subtypes in Parkinson’s disease: are non-tremor-dominant subtypes really uncorrelated to olfactory impairment? 93
Metabolomics as a Tool for the characterization of Drug-resistant epilepsy 93
VGF peptides as novel biomarkers in Parkinson’s disease 92
Tdp‐43 and herv‐k envelope‐specific immunogenic epitopes are recognized in als patients 91
The TANDEM investigation: efficacy and tolerability of levodopa-carbidopa intestinal gel in (LCIG) advanced Parkinson’s disease patients 91
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination 90
Fluctuating off-period hemidystonia with Pisa syndrome in advanced Parkinson's disease 90
Pisa syndrome in a patient with pathologically confirmed Parkinson's disease 90
Cerebellar continuous theta burst stimulation reduces levodopa-induced dyskinesias and decreases serum BDNF levels 89
Different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 89
Beneficial Effect of Phenytoin and Carbamazepine on GFAP Gene Expression and Mutant GFAP Folding in a Cellular Model of Alexander’s Disease 89
Teaching Video NeuroImage: Bilateral Hemifacial Spasm in Giant Cell Arteritis 88
Pisa-like syndrome under Baclofen in a patient with spastic hemiparesis due to ischemic stroke 88
The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonisms 87
Neurological and Psychiatric Disorders in the COVID-19 Era 86
A top-down proteomic approach reveals a salivary protein profile able to classify Parkinson's disease with respect to Alzheimer's disease patients and to healthy controls 84
Sardinian Folk Dance for Individuals with Parkinson's Disease: A Randomized Controlled Pilot Trial 84
Effects of a nordic walking program on motor and non-motor symptoms, functional performance and body composition in patients with Parkinson's disease 84
Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder 84
Description (reporting the actual words used in written letters) of the neuropsychological and psychopathological modifications produced by dopaminergic treatment in a young patient with Parkinson's disease 83
Effects of an adapted physical training on functional status, body composition and quality of life in persons with spinal cord injury paraplegia: a pilot study 81
Paraphilias and paraphilic disorders in Parkinson's disease: A systematic review of the literature 81
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study 81
Effect of olfactory and gustatory dysfunction and motor symptoms on body weight in patients with parkinson’s disease 80
Delusional jealousy in Parkinson's disease patients with and without dementia 80
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 80
Capgras syndrome in Parkinson’s disease: two new cases and literature review 80
Epidemiology of aquaporin-4-IgG-positive NMOSD in Sardinia 80
Epilepsy and sexual funtcion in male and female subjects treated with old and new AEDs, on poly or monotherapy: Preliminary data 79
Epidemiology of seropositive myasthenia gravis in Sardinia: A population-based study in the district of Sassari 78
Immune responses to oligomeric α-synuclein in Parkinson's disease peripheral blood mononuclear cells 78
A new national survey of centers for cognitive disorders and dementias in Italy 78
Effects of a mini-trampoline rebounding exercise program on functional parameters, body composition and quality of life in overweight women 78
Nonconvulsive status epilepticus as onset of Creutzfeldt-Jakob disease 77
Correlation among olfactory function, motors’ symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson’s disease 77
Study on the correlation among total burden of nonmotor symptoms and cardiovascular dysmodulation in Parkinson’s disease patients 77
Land- and water-based sports activities in natural environments as a group exercise for Parkinson’s disease: proof-of-concept pilot study 77
Diphasic dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion in Parkinson's disease 76
Clozapine-induced persistent hiccup in a patient with Alzheimer's disease 76
Seasonal variation in myasthenia gravis incidence 76
Olfactory Impairment Is the Main Predictor of Higher Scores at REM Sleep Behavior Disorder (RBD) Screening Questionnaire in Parkinson’s Disease Patients 75
Olfactory hallucinations in Parkinson's disease patients and the role of their evaluation in clinical practice 75
Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease 75
Heart rate variability shows different cardiovascular modulation in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 75
Nordic Walking for the Management of People With Parkinson Disease: A Systematic Review 74
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD: a literature review 73
Internal carotid artery dissection causing ischemic stroke during pole sport practice 73
Dopamine agonist withdrawal syndrome in Parkinson's disease 73
Neuroimaging evaluations of olfactory, gustatory, and neurological deficits in patients with long-term sequelae of COVID-19 73
Frequency and determinants of olfactory hallucinations in parkinson’s disease patients 72
Relationship between risk and protective factors and clinical features of Parkinson's disease 72
Current Advancement of Immunomodulatory Drugs as Potential Pharmacotherapies for Autoimmunity Based Neurological Diseases 71
Sex-related differences in olfactory function and evaluation of possible confounding factors among patients with Parkinson’s disease 71
Corrigendum to [123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism [Schizophr. Res. 113 (2009) 41-48] 71
The imbalance of serotonergic circuitry impairing the crop supercontractile muscle activity and the mitochondrial morphology of PD PINK1B9 Drosophila melanogaster are rescued by Mucuna pruriens 71
Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion 71
Hypersexual behaviour, frotteurism and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide: A rare case of iatrogenic paraphilia 71
Phantosmia in Parkinson’s Disease: A Systematic Review of the Phenomenology of Olfactory Hallucinations 70
Effects of an adapted physical activity program on motor and non-motor functions and quality of life in patients with Parkinson's disease 70
Treatment of benign essential blepharospasm with finasteride: A case report 70
Chronic inflammatory demyelinating polyneuropathy after chadox1 ncov-19 vaccination 70
Risk factors of Parkinson disease Simultaneous assessment, interactions, and etiologic subtypes 69
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 69
Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study 67
Olfactory Impairment in Parkinson’s Disease Patients with Tremor Dominant Subtype Compared to Those with Akinetic Rigid Dominant Subtype: A Pilot Study 67
Totale 9.768
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.705
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 0 0 0 0 0 0 16 0 25 88 0 3
2021/2022434 14 2 0 10 11 14 6 27 18 22 99 211
2022/20231.000 120 74 58 149 76 173 3 99 171 13 40 24
2023/2024335 55 28 7 6 47 5 6 38 4 3 40 96
2024/20254.727 76 59 279 99 155 137 227 985 1.726 668 186 130
2025/20266.631 250 1.728 2.012 1.438 883 320 0 0 0 0 0 0
Totale 13.388